Live Breaking News & Updates on India Formulations

Stay updated with breaking news from India formulations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Glenmark inks agreement with BeiGene for marketing and distribution of cancer drugs in India

Glenmark inks agreement with BeiGene for marketing and distribution of cancer drugs in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

China , India , Alok-malik , Adam-roach , Biocon-biologics , Glenmark-pharmaceuticals-ltd , Business-head , India-formulations , Glenmark-pharmaceuticals , New-covid-variant , Vice-president ,

Glenmark to bring into India, two cancer drugs from BeiGene

Glenmark Specialty SA partners with BeiGene to bring innovative oncology drugs to India, addressing rising cancer rates. ....

United-states , Hong-kong , Australia , India , Shanghai , China , America , Alok-malik , Adam-roach , Linkedin , Twitter , Facebook

Glenmark partners with Pfizer to launch oral drug for atopic dermatitis in India

Glenmark partners with Pfizer to launch oral drug for atopic dermatitis in India
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India , China , Japan , Meenakshi-nevatia , Alok-malik , Central-drugs-standard-control-organization , Glenmark-pharmaceuticals-ltd , Drug-administration , Pfizer , European-medicines-agency , Glenmark-pharmaceuticals , Country-president

Glenmark partners with Pfizer to launch abrocitinib in India to treat atopic dermatitis

Glenmark and Pfizer will co-market abrocitinib in India under the brand names JABRYUS and CIBINQO. Developed by Pfizer, abrocitinib has received marketing authorization for abrocitinib in adults with moderate-to-severe atopic dermatitis from the Central Drugs Standard Control Organization (CDSCO). It is also approved by the USFDA, European Medicines Agency (EMA), and other regulatory agencies. ....

India , Japan , China , Alok-malik , Meenakshi-nevatia , European-medicines-agency , Pfizer , Central-drugs-standard-control-organization , India-formulations , Abrocitinib , Atopic-dermatitis , Glenmark